These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31477366)

  • 1. Can the Jankovic-assessment be used as an alternative to electromyography? A cross-sectional study on facial dystonia patients treated with Botulinum toxin.
    Di Stadio A; Dipietro L; Gambacorta V; Cristi MC; Faralli M; Della Volpe A; Ricci G
    Am J Otolaryngol; 2019; 40(6):102278. PubMed ID: 31477366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
    JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
    Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
    Winterhoff J; Laskawi R
    HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hemifacial spasm with botulinum A toxin].
    Duzyński W; Sławek J
    Neurol Neurochir Pol; 1998; 32 Suppl 1():61-9. PubMed ID: 9608555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H
    Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose.
    Badarny S; Ibrahim R; Susel Z; Zaina A; Nasar R; Badarny Y
    Medicine (Baltimore); 2021 Jun; 100(25):e26481. PubMed ID: 34160460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of botulinum toxin A on ephaptic transmission in idiopathic hemifacial spasm.
    Kurt T; Seçil Y; Gürgör N; Tokuçoğlu F; Beckmann Y; Ertekin C
    Int J Neurosci; 2009; 119(11):2044-55. PubMed ID: 19863260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
    Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
    Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
    Colakoglu BD; Cakmur R; Uzunel F
    Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.
    Su JH; Yang MN; Teng F; Zhang XL; Pan YG; Hu Y; Xiao LB; Pan LZ; Li LX; Jin LJ
    Toxicon; 2020 Sep; 184():122-126. PubMed ID: 32553733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].
    Yabiku MM; Sartori Jde F; Sarraff EP; Osaki TH; Hossaka SK; Pereira CI; Freitas Wd; Osaki MH; Cariello AJ
    Arq Bras Oftalmol; 2011; 74(6):414-6. PubMed ID: 22331113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccinator synkinesis treated by botulinum toxin in facial palsy and hemifacial spasms.
    Kanerva M
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1464-1469. PubMed ID: 33358465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
    Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular retraining therapy combined with preceding botulinum toxin A injection for chronic facial paralysis.
    Jeong J; Lee JM; Kim J
    Acta Otolaryngol; 2023 May; 143(5):446-451. PubMed ID: 37173287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.